Allogeneic donor-derived CD19/CD22-CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic donor-derived CD19/CD22-CAR T cells, covering 2025-09-16 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL [Phase 1]